Amyloid Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Amyloid stocks.

Amyloid Stocks Recent News

Date Stock Title
May 9 LLY Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
May 9 LLY Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
May 9 IONS The Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) First-Quarter Results Are Out And Analysts Have Published New Forecasts
May 9 NTLA Intellia Therapeutics GAAP EPS of -$1.12 beats by $0.25, revenue of $28.94M beats by $19.87M
May 9 NTLA Intellia Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
May 9 ANVS Annovis Announces Unblinding of the Buntanetap Phase III Data in Parkinson’s Disease
May 9 ANVS Acadia (ACAD) Q1 Earnings Surpass Estimates, Revenues Miss
May 8 PRTA Prothena (PRTA) Reports Q1 Loss, Lags Revenue Estimates
May 8 ABOS Acumen Pharmaceuticals to Participate in the 2024 Bank of America Healthcare Conference
May 8 PRTA Prothena GAAP EPS of -$1.34 misses by $0.12, revenue of $0.05M misses by $2.12M
May 8 PRTA Prothena Reports First Quarter 2024 Financial Results and Business Highlights
May 8 IONS Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Q1 2024 Earnings Call Transcript
May 8 ANVS Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates
May 8 NTLA Intellia Therapeutics Q1 2024 Earnings Preview
May 8 ANVS Pacira (PCRX) Q1 Earnings Miss, Exparel Sales Drive Revenues
May 8 IONS Ionis (IONS) Q1 Loss Narrower Than Expected, Sales Miss
May 8 LLY Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
May 8 ABOS Acumen Pharmaceuticals Announces First Patient Dosed in ALTITUDE-AD, a Phase 2 Clinical Trial of Sabirnetug (ACU193) in Early Alzheimer’s Disease
May 8 IONS Ionis Pharmaceuticals First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
May 8 PRTA We think Prothena Corporation plc's (NASDAQ:PRTA) CEO May Struggle To See Much Of A Pay Rise This Year
Amyloid

Amyloids are aggregates of proteins characterised by a fibrillar morphology of 7–13 nm in diameter, a β-sheet secondary structure (known as cross-β) and ability to be stained by particular dyes, such as Congo red. In the human body, amyloids have been linked to the development of various diseases. Pathogenic amyloids form when previously healthy proteins lose their normal structure and physiological functions (misfolding) and form fibrous deposits in plaques around cells which can disrupt the healthy function of tissues and organs.
Such amyloids have been associated with (but not necessarily as the cause of) more than 50 human diseases, known as amyloidosis, and may play a role in some neurodegenerative disorders. Some of these diseases are mainly sporadic and only a few cases are familial. Others are only familial. Some are iatrogenic as they result from medical treatment. One amyloid protein is infectious and is called prion in which the infectious form can act as a template to convert other non-infectious proteins into infectious form. Amyloids may also have normal biological functions; for example, in the formation of fimbriae in some genera of bacteria, transmission of epigenetic traits in fungi, as well as pigment deposition and hormone release in humans.Amyloids have been known to arise from many different proteins. These polypeptide chains generally form β-sheet structures that aggregate into long fibers; however, identical polypeptides can fold into multiple distinct amyloid conformations. The diversity of the conformations may have led to different forms of the prion diseases.

Browse All Tags